Head and neck cancer metastatic

4 clinical trials

Quick filters

Clinical trials for Head and neck cancer metastatic

4 trials across Europe

See all trials →

Quick filters

4 Clinical trials

Head and neck cancer metastatic

Recruiting

Registered drugNo placebo

Comparing Two Treatment Lengths of Cetuximab, Avelumab, Cisplatin, and Docetaxel for Patients with Returning Spread Head and Neck Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Avelumab
Sponsor:Charite Universitaetsmedizin Berlin KöR

Contact Research Centre

Head and neck cancer metastatic

Not recruiting

Registered drugNo placebo

Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Eftilagimod Alfa
Sponsor:Immutep

Contact Research Centre

Colorectal cancer metastatic+14

Not recruiting

Registered drugNo placebo

Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Seagen Inc.

Contact Research Centre

Squamous cell carcinoma of head and neck+7

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Institut Gustave Roussy

Contact Research Centre

See all trials →

Head and neck cancer metastatic

Clinical trials for Head and neck cancer metastatic

Head and neck cancer metastatic

Comparing Two Treatment Lengths of Cetuximab, Avelumab, Cisplatin, and Docetaxel for Patients with Returning Spread Head and Neck Cancer

Head and neck cancer metastatic

Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

Colorectal cancer metastatic+14

Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

Squamous cell carcinoma of head and neck+7

Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.